16-20348311-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003361.4(UMOD):​c.885G>A​(p.Gly295Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.172 in 1,614,024 control chromosomes in the GnomAD database, including 25,159 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G295G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.15 ( 1916 hom., cov: 33)
Exomes 𝑓: 0.17 ( 23243 hom. )

Consequence

UMOD
NM_003361.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.49

Publications

15 publications found
Variant links:
Genes affected
UMOD (HGNC:12559): (uromodulin) The protein encoded by this gene is the most abundant protein in mammalian urine under physiological conditions. Its excretion in urine follows proteolytic cleavage of the ectodomain of its glycosyl phosphatidylinosital-anchored counterpart that is situated on the luminal cell surface of the loop of Henle. This protein may act as a constitutive inhibitor of calcium crystallization in renal fluids. Excretion of this protein in urine may provide defense against urinary tract infections caused by uropathogenic bacteria. Defects in this gene are associated with the renal disorders medullary cystic kidney disease-2 (MCKD2), glomerulocystic kidney disease with hyperuricemia and isosthenuria (GCKDHI), and familial juvenile hyperuricemic nephropathy (FJHN). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2013]
UMOD Gene-Disease associations (from GenCC):
  • autosomal dominant medullary cystic kidney disease with or without hyperuricemia
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • glomerulocystic kidney disease with hyperuricemia and isosthenuria
    Inheritance: AD Classification: DEFINITIVE Submitted by: Laboratory for Molecular Medicine
  • familial juvenile hyperuricemic nephropathy type 1
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal dominant medullary cystic kidney disease with hyperuricemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 16-20348311-C-T is Benign according to our data. Variant chr16-20348311-C-T is described in ClinVar as Benign. ClinVar VariationId is 94132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.49 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.178 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UMODNM_003361.4 linkc.885G>A p.Gly295Gly synonymous_variant Exon 4 of 11 ENST00000396138.9 NP_003352.2 P07911-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UMODENST00000396138.9 linkc.885G>A p.Gly295Gly synonymous_variant Exon 4 of 11 5 NM_003361.4 ENSP00000379442.5 P07911-1X6RBG4
UMODENST00000396134.6 linkc.984G>A p.Gly328Gly synonymous_variant Exon 5 of 12 2 ENSP00000379438.2 P07911-5
UMODENST00000570689.5 linkc.885G>A p.Gly295Gly synonymous_variant Exon 4 of 11 5 ENSP00000460548.1 P07911-1

Frequencies

GnomAD3 genomes
AF:
0.149
AC:
22644
AN:
152168
Hom.:
1912
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0797
Gnomad AMI
AF:
0.276
Gnomad AMR
AF:
0.171
Gnomad ASJ
AF:
0.148
Gnomad EAS
AF:
0.0121
Gnomad SAS
AF:
0.167
Gnomad FIN
AF:
0.226
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.181
Gnomad OTH
AF:
0.156
GnomAD2 exomes
AF:
0.159
AC:
40022
AN:
251440
AF XY:
0.164
show subpopulations
Gnomad AFR exome
AF:
0.0749
Gnomad AMR exome
AF:
0.145
Gnomad ASJ exome
AF:
0.144
Gnomad EAS exome
AF:
0.0117
Gnomad FIN exome
AF:
0.222
Gnomad NFE exome
AF:
0.181
Gnomad OTH exome
AF:
0.179
GnomAD4 exome
AF:
0.174
AC:
254267
AN:
1461738
Hom.:
23243
Cov.:
36
AF XY:
0.175
AC XY:
126913
AN XY:
727182
show subpopulations
African (AFR)
AF:
0.0835
AC:
2794
AN:
33480
American (AMR)
AF:
0.151
AC:
6733
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.143
AC:
3731
AN:
26136
East Asian (EAS)
AF:
0.00562
AC:
223
AN:
39700
South Asian (SAS)
AF:
0.187
AC:
16147
AN:
86254
European-Finnish (FIN)
AF:
0.224
AC:
11940
AN:
53388
Middle Eastern (MID)
AF:
0.195
AC:
1127
AN:
5768
European-Non Finnish (NFE)
AF:
0.181
AC:
201613
AN:
1111894
Other (OTH)
AF:
0.165
AC:
9959
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
13966
27932
41898
55864
69830
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7012
14024
21036
28048
35060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.149
AC:
22648
AN:
152286
Hom.:
1916
Cov.:
33
AF XY:
0.151
AC XY:
11206
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.0798
AC:
3320
AN:
41578
American (AMR)
AF:
0.171
AC:
2616
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.148
AC:
512
AN:
3470
East Asian (EAS)
AF:
0.0118
AC:
61
AN:
5190
South Asian (SAS)
AF:
0.166
AC:
799
AN:
4816
European-Finnish (FIN)
AF:
0.226
AC:
2391
AN:
10602
Middle Eastern (MID)
AF:
0.190
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
0.181
AC:
12308
AN:
68008
Other (OTH)
AF:
0.158
AC:
333
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
990
1981
2971
3962
4952
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.158
Hom.:
3798
Bravo
AF:
0.141
Asia WGS
AF:
0.0990
AC:
348
AN:
3478
EpiCase
AF:
0.182
EpiControl
AF:
0.186

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 10, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial juvenile hyperuricemic nephropathy type 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
4.6
DANN
Benign
0.92
PhyloP100
-1.5
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28544423; hg19: chr16-20359633; COSMIC: COSV56773565; COSMIC: COSV56773565; API